2017 American Transplant Congress

Tuesday, May 2, 2017

6:00pm-7:00pm

Effect of Everolimus on the Cardiac Function in Kidney Transplant Recipients.

K. Tsujimura,¹ M. Ota,¹ H. Ishida,² K. Tanabe.²

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Effect of Everolimus-Based Regimen on Graft Outcomes in Kidney Transplant Recipients with Diabetes at Baseline: Post-Hoc Analysis from the ELEVATE Study.

J. de Fijter,¹ H. Holdaas,¹ J. Sanders,¹ S. Sundar,¹ F. Bemelman,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ M. van der Giet.¹

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Effect of Hepatitis C (HCV) Treatment on Rejection Incidence and Severity in Post-Liver Transplant Patients.

C. Skillin, M. Mba, B. Madani, C. Frenette.

Poster Session D: Liver: Immunosuppression and Rejection  •  Hall D1

6:00pm-7:00pm

Effect of HLA-DQ Mismatch on Efficacy Outcomes and Renal Function in Kidney Transplant Recipients: Subanalysis from the ELEVATE Study.

W. Arns,¹ J. Cruzado,¹ H. Holdaas,¹ P. Lopez,² P. Bernhardt,² G. Bader,² F. Claas,¹ M. van der Giet,¹ J. de Fijter.¹

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Efficacy of Calcineurin Inhibitors Transferring to Rapamycin in Live Kidney Transplantation from Old Donors to Young Recipients.

G. Chen, C. Wang, Z. Wu, C. Wang, J. Qiu, L. Chen.

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1

6:00pm-7:00pm

Enhanced Hepatic Engraftment of Stem Cell Derivatives Using Magnetic Targeting into Structurally Normal Liver.

N. Liu, S. Fagg, J. Fair.

Poster Session D: Cellular & Bone Marrow Transplantation Session II  •  Hall D1

6:00pm-7:00pm

Enhanced Recovery After Surgery Pathway for Living Donor Nephrectomy Patients Decreases Length of Stay and Narcotic Utilization.

R. Forbes,¹ A. King,² T. McGrane,² D. Hale,¹ W. Sandberg,² J. Wanderer,² M. McEvoy.²

Poster Session D: Living Donor Kidney Transplant II  •  Hall D1

6:00pm-7:00pm

ERK and HIF1 Play a Major Role in Hypothermic Protection Against Renal Ischemia-Reperfusion Injury.

K. Lee,¹ J. Jeong,² D. Choi,¹ K. Na,¹ H. Bae,¹ Y. Ham.¹

Poster Session D: Ischemic Injury and Organ Preservation Session III  •  Hall D1

6:00pm-7:00pm

Evaluation of Renal Function After a Transition to Everolimus or Mycophenolate Mofetil in Liver Transplant Recipients.

C. Perez,¹ J. Fleming,¹ M. Sell,¹ B. O'brien,¹ A. Rogers,¹ I. Lee,¹ C. Mardis,¹ A. Mardis,¹ N. Patel,¹ H. Meadows,¹ N. Pilch,² K. Chavin,² D. Dubay,² R. Vinayak,² D. Taber.²

Poster Session D: Liver: Immunosuppression and Rejection  •  Hall D1

6:00pm-7:00pm

Evaluation of the Conversion from Brand Name to Generic Immunosuppression in Hospitalized Organ Transplant Recipients.

L. DeZotell,¹ K. Blunck,¹ J. Guy,¹ M. Woods,¹ M. Reffett,² J. Terrell,² A. Palermo,² K. Gosch,³ L. Cummings.⁴

Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization  •  Hall D1